Your browser doesn't support javascript.
loading
A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.
Duits, L C; Lao-Sirieix, P; Wolf, W A; O'Donovan, M; Galeano-Dalmau, N; Meijer, S L; Offerhaus, G J A; Redman, J; Crawte, J; Zeki, S; Pouw, R E; Chak, A; Shaheen, N J; Bergman, J J G H M; Fitzgerald, R C.
Afiliação
  • Duits LC; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, the Netherlands.
  • Lao-Sirieix P; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
  • Wolf WA; Center for Esophageal Diseases and Swallowing, Department of Medicine, Division of Gastroenterology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • O'Donovan M; Department of Pathology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.
  • Galeano-Dalmau N; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
  • Meijer SL; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Offerhaus GJA; Department of Pathology, University Medical Center, Utrecht, the Netherlands.
  • Redman J; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
  • Crawte J; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
  • Zeki S; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
  • Pouw RE; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, the Netherlands.
  • Chak A; Division of Gastroenterology and Liver Disease, Case Western Reserve University, Cleveland, Ohio, USA.
  • Shaheen NJ; Center for Esophageal Diseases and Swallowing, Department of Medicine, Division of Gastroenterology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Bergman JJGHM; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, the Netherlands.
  • Fitzgerald RC; Medical Research Council Cancer Unit, Hutchison-MRC Research Center, University of Cambridge,Cambridge,United Kingdom.
Dis Esophagus ; 32(1)2019 Jan 01.
Article em En | MEDLINE | ID: mdl-30496496
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Vigilância da População / Medição de Risco / Esôfago Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Vigilância da População / Medição de Risco / Esôfago Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article